MUC16 and ovarian cancer: We recently demonstrated the analytical and clinical performance of MIA3G, a deep neural network-based algorithm that incorporates the combination of CA125 and HE4 in addition to five other biomarkers, along with age and menopausal status, as input features to assess ovarian cancer risk.